|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print January 17, 2002
Am J Physiol Regu Physiol, 10.1152/ajpregu.00486.2001
Submitted on August 14, 2001
Accepted on January 15, 2002
1 Neuroscience Research, Eli Lilly and Company, Indianapolis, IN, USA
2 Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
* To whom correspondence should be addressed. E-mail: stengel_peter_w{at}lilly.com.
Negative chronotropic and smooth muscle contractile responses to the nonselective muscarinic agonist carbamylcholine were compared in isolated tissues from M3 muscarinic receptor knockout and wild-type mice. Carbamylcholine (10-8-3.0x10-5M) induced a concentration-dependent decrease in atrial rate that was similar in atria from M3 receptor knockout and wild-type mice, indicating that M3 receptors were not involved in muscarinic receptor-mediated atrial rate decreases. In contrast, the M3 receptor was a major muscarinic receptor involved in smooth muscle contraction of stomach fundus, urinary bladder and trachea, although differences existed in the extent of M3 receptor involvement among the tissues. Contraction to carbamylcholine was virtually abolished in urinary bladder from M3 receptor knockout mice suggesting that contraction was predominantly due to M3 receptor activation. However, approximately 50-60% maximal contraction to carbamylcholine occurred in stomach fundus and trachea from M3 receptor knockout mice, indicating that contraction in these tissues was also due to M2 receptor activation. High concentrations of carbamylcholine relaxed the stomach fundus from M3 receptor knockout mice by M1 receptor activation. Thus, M3 receptor knockout mice provided unambiguous evidence that M3 receptors 1) play no role in carbamylcholine-induced atrial rate reduction, 2) are the predominant receptor mediating carbamylcholine-induced urinary bladder contractility and 3) share contractile responsibility with M2 receptors in mouse stomach fundus and trachea.
This article has been cited by other articles:
![]() |
M. Sausbier, X.-B. Zhou, C. Beier, U. Sausbier, D. Wolpers, S. Maget, C. Martin, A. Dietrich, A.-R. Ressmeyer, H. Renz, et al. Reduced rather than enhanced cholinergic airway constriction in mice with ablation of the large conductance Ca2+-activated K+ channel FASEB J, March 1, 2007; 21(3): 812 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takeuchi, K. Tanaka, H. Nakajima, M. Matsui, and Y.-T. Azuma M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: findings obtained with muscarinic-receptor knockout mouse Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G154 - G164. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Ng, W. C. de Groat, and H.-Y. Wu Muscarinic regulation of neonatal rat bladder spontaneous contractions Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R1049 - R1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Belmonte Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kovacs, I. Marczinovits, A. Gyorgy, G. K. Toth, L. Dorgai, J. Pal, J. Molnar, and G. Pokorny Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3213-228 in primary Sjogren's syndrome Rheumatology, August 1, 2005; 44(8): 1021 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-E. Andersson and A. Arner Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology Physiol Rev, July 1, 2004; 84(3): 935 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Lamping, J. Wess, Y. Cui, D. W. Nuno, and F. M. Faraci Muscarinic (M) Receptors in Coronary Circulation: Gene-Targeted Mice Define the Role of M2 and M3 Receptors in Response to Acetylcholine Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pontari, A. S. Braverman, and M. R. Ruggieri Sr. The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R874 - R880. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. McGowan, A. J. Holmes, and J. Smith Retinoic acid reverses the airway hyperresponsiveness but not the parenchymal defect that is associated with vitamin A deficiency Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L437 - L444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. L. Walker, R. R. Gainetdinov, D. S. Feldman, P. K. McFawn, M. G. Caron, R. J. Lefkowitz, R. T. Premont, and J. T. Fisher G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L312 - L319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsui, M. T. Griffin, D. Shehnaz, M. M. Taketo, and F. J. Ehlert Increased Relaxant Action of Forskolin and Isoproterenol against Muscarinic Agonist-Induced Contractions in Smooth Muscle from M2 Receptor Knockout Mice J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 106 - 113. [Abstract] [Full Text] |
||||
![]() |
P. W. Stengel and M. L. Cohen M1 Receptor-Mediated Nitric Oxide-Dependent Relaxation Unmasked in Stomach Fundus from M3 Receptor Knockout Mice J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 675 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ehmke Mouse gene targeting in cardiovascular physiology Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R28 - R30. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |